Animal Healthcare Market Report 2023 | R&D Consistency Drives Sector Growth

The Animal Healthcare Market Sales is expected to be valued US$ 40.9 billion in 2023 and US$ 62.3 billion by 2033, rising at a 4.3% CAGR during the forecast period.

One of the primary causes of this increase is the growing occurrence of zoonotic diseases such as animal flu, tick infestation, and Lyme disease. Pet adoption for companionship has led in an increase in animal-borne diseases, resulting in a greater demand for sufficient Animal Healthcare. Furthermore, the availability of Animal Healthcare goods and services, as well as growing public knowledge of the benefits of early diagnosis and preventive actions, are boosting the market.

Another issue is that people's health consciousness is expanding, which is raising demand for protein-rich foods such as poultry, fish, beef, and meat. The global expansion of veterinary hospitals, as well as online and offline distribution channels, is also helping to boost the market's outlook.

Furthermore, market growth is being fueled by the development of cutting-edge technology systems that allow critical data collected in veterinary clinics to be uploaded to the internet and shared with clinicians. Rising R&D activities in the healthcare industry to investigate the efficacy of pharmaceuticals and medical devices are also propelling the market.

Finally, the use of animals in the development of medications for the research of several genetic and chronic human diseases is fueling market growth.

Some of the Key Players Operating in the \ Market Include:

Neogen, Zoetis, Merck, Boehringer Ingelheim, Elanco, Dechra Pharmaceuticals, IDEXX Laboratories, B. Braun Vet Care, and Medtronic.

Browse More@ https://www.futuremarketinsights.com/reports/animal-healthcare-market

Animal Healthcare Market Segmentation

Product Type:

  • Feed Additives
  • Pharmaceuticals
  • Vaccines

Animal Type:

  • Production Animals
  • Companion Animals

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Antidiabetics Market to reach US$ 223 billion by 2032, growing at a 9.6% CAGR from 2022 to 2032 | Future Market Insights, Inc.

Image
The global Antidiabetics Market is expected to earn US$ 223 billion while expanding at a CAGR of 9.6% during the forecast period. The rising prevalence of diabetes worldwide can be attributed to the market's expansion. The ageing baby boomer population is another factor driving the market during the forecast period. According to the International Diabetes Federation, the global diabetes incidence will increase from 366 million in 2011 to 552 million by 2030. During the forecast period, the industry is expected to benefit from a significant increase in the number of diabetic patients. Furthermore, new product development is expected to benefit the market in the near future. For example, Novo Nordisk, a Danish pharmaceutical company, announced the launch of oral semaglutide for the treatment of Type 2 diabetes in India in January 2022. Furthermore, the development of advanced pumps based on smart technologies like AI and ML is expected to open up a slew of new doors. For exampl
Read more